日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

开发和评估基于多重质谱的检测方法,用于测量阿尔茨海默病神经影像学倡议 (ADNI) CSF 中的候选肽生物标志物

Daniel S Spellman, Kristin R Wildsmith, Lee A Honigberg, Marianne Tuefferd, David Baker, Nandini Raghavan, Angus C Nairn, Pascal Croteau, Michael Schirm, Rene Allard, Julie Lamontagne, Daniel Chelsky, Steven Hoffmann, William Z Potter; Alzheimer's Disease Neuroimaging Initiative; Foundation for NIH